382 related articles for article (PubMed ID: 34251716)
1. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
[TBL] [Abstract][Full Text] [Related]
2. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
Peyko V; Finamore M
Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
[TBL] [Abstract][Full Text] [Related]
3. Vasoplegia During Cardiopulmonary Bypass: Current Literature and Rescue Therapy Options.
Ortoleva J; Shapeton A; Vanneman M; Dalia AA
J Cardiothorac Vasc Anesth; 2020 Oct; 34(10):2766-2775. PubMed ID: 31917073
[TBL] [Abstract][Full Text] [Related]
4. Hydroxocobalamin or Methylene Blue for Vasoplegic Syndrome in Adult Cardiothoracic Surgery.
Kram SJ; Kram BL; Cook JC; Ohman KL; Ghadimi K
J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):469-476. PubMed ID: 34176677
[TBL] [Abstract][Full Text] [Related]
5. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative Versus Postoperative Hydroxocobalamin for Vasoplegic Shock in Cardiothoracic Surgery.
Khandekar DA; Seelhammer TG; Mara KC; Stephens EH; Wittwer ED; Wieruszewski PM
J Cardiothorac Vasc Anesth; 2023 Dec; 37(12):2538-2545. PubMed ID: 37723020
[TBL] [Abstract][Full Text] [Related]
7. Hydroxocobalamin for the treatment of cardiac surgery-associated vasoplegia: a case series.
Shah PR; Reynolds PS; Pal N; Tang D; McCarthy H; Spiess BD
Can J Anaesth; 2018 May; 65(5):560-568. PubMed ID: 29209927
[TBL] [Abstract][Full Text] [Related]
8. Use of hydroxocobalamin to treat intraoperative vasoplegic syndrome refractory to vasopressors and methylene blue during liver transplantation.
Pai SL; Torp KD; Insignares VC; DeMaria S; Giordano CR; Logvinov II; Li Z; Chadha R; Aniskevich S
Clin Transplant; 2024 Mar; 38(3):e15271. PubMed ID: 38485687
[TBL] [Abstract][Full Text] [Related]
9. The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Albertson TE; Chenoweth JA; Lewis JC; Pugashetti JV; Sandrock CE; Morrissey BM
Expert Rev Clin Pharmacol; 2022 Aug; 15(8):959-976. PubMed ID: 35920615
[TBL] [Abstract][Full Text] [Related]
10. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
Nash CM
AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
[TBL] [Abstract][Full Text] [Related]
11. Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
Feih JT; Rinka JRG; Zundel MT
J Cardiothorac Vasc Anesth; 2019 May; 33(5):1301-1307. PubMed ID: 30606508
[TBL] [Abstract][Full Text] [Related]
12. Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass.
Muhammad R; Dharmadjati BB; Mulia EPB; Rachmi DA
Eurasian J Med; 2022 Feb; 54(1):92-99. PubMed ID: 35307639
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.
Noto A; Lentini S; Versaci A; Giardina M; Risitano DC; Messina R; David A
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):588-92. PubMed ID: 19581293
[TBL] [Abstract][Full Text] [Related]
14. Vasoplegic Syndrome after Cardiopulmonary Bypass in Cardiovascular Surgery: Pathophysiology and Management in Critical Care.
Ltaief Z; Ben-Hamouda N; Rancati V; Gunga Z; Marcucci C; Kirsch M; Liaudet L
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362635
[TBL] [Abstract][Full Text] [Related]
15. Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.
Armour S; Armour TK; Joppa WR; Maltais S; Nelson JA; Wittwer E
Anesth Analg; 2019 Jul; 129(1):e1-e4. PubMed ID: 29979199
[TBL] [Abstract][Full Text] [Related]
16. The use of intravenous hydroxocobalamin as a rescue in methylene blue-resistant vasoplegic syndrome in cardiac surgery.
Cai Y; Mack A; Ladlie BL; Martin AK
Ann Card Anaesth; 2017; 20(4):462-464. PubMed ID: 28994688
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass.
Javorski MJ; Kerolos MM; Fareed J; Perez-Tamayo RA
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1322-1326. PubMed ID: 29730947
[TBL] [Abstract][Full Text] [Related]
18. The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery.
Petermichl W; Gruber M; Schoeller I; Allouch K; Graf BM; Zausig YA
J Cardiothorac Surg; 2021 Jul; 16(1):205. PubMed ID: 34321019
[TBL] [Abstract][Full Text] [Related]
19. Hydroxocobalamin Versus Methylene Blue for Vasoplegic Syndrome in Cardiothoracic Surgery: A Retrospective Cohort.
Furnish C; Mueller SW; Kiser TH; Dufficy L; Sullivan B; Beyer JT
J Cardiothorac Vasc Anesth; 2020 Jul; 34(7):1763-1770. PubMed ID: 32115360
[TBL] [Abstract][Full Text] [Related]
20. Vasoplegia: A Review.
Ratnani I; Ochani RK; Shaikh A; Jatoi HN
Methodist Debakey Cardiovasc J; 2023; 19(4):38-47. PubMed ID: 37547893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
